| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10899325 | Cancer Letters | 2016 | 7 Pages |
Abstract
The present mini-review summarizes the current state of definition, management and outcome of BR-PDAC. Furthermore, the topic of ongoing and future studies on neoadjuvant treatment which is closely related to borderline resectability in PDAC is discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thilo Hackert, Alexis Ulrich, Markus W. Büchler,